Star Imaging And Path Lab
73.50
+3.50(+5.00%)
Market Cap₹128.00 Cr
PE Ratio6.33
Company Performance:
1D+5.00%
1M-6.32%
6M-44.32%
1Y-45.94%
5Y-45.94%
View Company Insightsright
More news about Star Imaging And Path Lab
21Jan 26
Star Imaging and Path Lab Limited Secures 5-Year Empanelment with Indian National Science Academy
Star Imaging and Path Lab Limited has secured empanelment with the Indian National Science Academy (INSA) to provide medical diagnostic and laboratory services for a five-year period. The arrangement covers medical treatment for INSA officers, employees, and their dependent family members at CGHS approved rates. The company disclosed this development on January 21, 2026, noting it represents ordinary course business that does not materially impact financial position.
 no imag found
21Jan 26
Star Imaging and Path Lab Secures Delhi High Court Medical Services Contract
Star Imaging and Path Lab Limited has secured approval from the High Court of Delhi to provide credit and cashless medical services to all serving court officers and officials, including their families. The arrangement operates under CGHS norms and is part of the company's ordinary business course without material financial impact.
 no imag found
14Jan 26
Star Imaging And Path Lab: CERC Selects Co For Medical Services
Star Imaging And Path Lab Limited has been empaneled by the Central Electricity Regulatory Commission (CERC) to provide medical diagnostic and laboratory services for a three-year period. The empanelment covers comprehensive medical services for CERC officers, employees, and their dependent family members at CGHS approved rates, representing a stable government sector contract for the healthcare company.
 no imag found
13Jan 26
Star Imaging and Path Lab Limited Receives ICSSR Empanelment for Medical Services
Star Imaging and Path Lab Limited has been empanelled by the Indian Council of Social Science Research (ICSSR) to provide medical diagnostic and laboratory services to ICSSR pensioners, employees, and their dependents at CGHS approved rates. The two-year empanelment was disclosed on January 13, 2026, as part of regulatory compliance under SEBI Listing Regulations, with the company noting it does not constitute a material financial event.
 no imag found
07Jan 26
Star Imaging and Path Lab Secures Supreme Court Medical Services Contract
Star Imaging and Path Lab Limited has received approval from the Supreme Court of India to provide credit/cashless medical services to all serving officers, officials, and their dependent family members under CGHS norms. The company disclosed this development on January 7, 2026, classifying it as ordinary business operations without material financial impact. The arrangement will be governed by applicable laws, CGHS guidelines, and internal company policies.
 no imag found
02Jan 26
Star Imaging and Path Lab Secures WDRA Empanelment for Medical Services
Star Imaging and Path Lab Limited has secured empanelment with the Warehousing Development and Regulatory Authority (WDRA) Government of India for providing medical diagnostic and laboratory services to officers, employees, and their dependents at CGHS approved rates. The three-year empanelment adds to the company's existing CGHS empanelment and advanced imaging facilities including CT scan and 3 Tesla MRI at its Vikaspuri center, strengthening its position in the diagnostic healthcare sector.
 no imag found
Star Imaging And Path Lab
73.50
+3.50
(+5.00%)
1 Year Returns:-45.94%
Industry Peers
Dr. Lal Path Labs
1,569.60
(+0.55%)
Vijaya Diagnostic Centre
1,275.40
(-3.16%)
Metropolis Healthcare
536.15
(-0.99%)
Krsnaa Diagnostics
541.00
(-0.68%)
Suraksha Diagnostic
292.40
(+0.74%)
3B BlackBio DX
1,149.00
(+3.19%)
Health X Platform
300.80
(-0.22%)